High IL-18 (interferon-γ inducing factor) concentration in a purine nucleoside phosphorylase deficient patient

被引：8

作者：

Yamamoto, T

Moriwaki, Y

Matsui, K

Takahashi, S

Tsutsui, H

Yoshimoto, T

Okamura, H

Nakanishi, K

Kurosawa, Y

Yamaguchi, S

Sasaki, Y

Higashino, K

机构：

[1] Hyogo Coll Med, Dept Internal Med 3, Nishinomiya, Hyogo 6638501, Japan

[2] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan

[3] Hyogo Coll Med, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan

[4] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan

[5] Kitasato Inst Hosp, Dept Pediat, Tokyo, Japan

[6] Natl Inst Infect Dis, Dept Safety Res Biol, Tokyo, Japan

来源：

ARCHIVES OF DISEASE IN CHILDHOOD | 1999年 / 81卷 / 02期

关键词：

purine nucleoside phosphorylase deficiency; interferon-gamma inducing factor; cytokines;

D O I：

10.1136/adc.81.2.179

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The plasma concentration of IL-18 (interferon-gamma inducing factor) was severely increased in a 3 year old boy with purine nucleoside phosphorylase (PNP) deficiency. The presence and activity of IL-18 were confirmed by immunoblotting and bioassay, respectively. These results suggest that IL-18 may be abundantly produced and secreted into plasma by PNP deficient macrophages in PNP deficiency.

引用

页码：179 / 180

页数：2

共 50 条

[1] Interferon-γ-inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases
Fassbender, K
Mielke, O
Bertsch, T
Muehlhauser, F
Hennerici, M
Kurimoto, M
Rossol, S
NEUROLOGY, 1999, 53 (05) : 1104 - 1106
[2] ABNORMAL PURINE METABOLISM AND PURINE OVERPRODUCTION IN A PATIENT DEFICIENT IN PURINE NUCLEOSIDE PHOSPHORYLASE
COHEN, A
DOYLE, D
MARTIN, DW
AMMANN, AJ
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (26): : 1449 - 1454
[3] Deficient production of interferon-γ, IL-12 and IL-18 in RSV bronchiolitis.
Legg, JP
Hussain, IR
Johnston, SL
Warner, JO
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A244 - A244
[4] Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18)
Osaki, T
Hashimoto, W
Gambotto, A
Okamura, H
Robbins, PD
Kurimoto, M
Lotze, MT
Tahara, H
GENE THERAPY, 1999, 6 (05) : 808 - 815
[5] Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18)
T Osaki
W Hashimoto
A Gambotto
H Okamura
P D Robbins
M Kurimoto
M T Lotze
H Tahara
Gene Therapy, 1999, 6 : 808 - 815
[6] Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient
Dalal, I
Grunebaum, E
Cohen, A
Roifman, CM
CLINICAL GENETICS, 2001, 59 (06) : 430 - 437
[7] Regulation of interferon-γ production by IL-12 and IL-18
Okamura, H
Kashiwamura, S
Tsutsui, H
Yoshimoto, T
Nakanishi, K
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) : 259 - 264
[8] The possible role of interleukin (IL)-12 and interferon-γ-inducing factor IL-18 in protection against experimental Mycobacterium leprae infection in mice
Kobayashi, K
Kai, M
Gidoh, M
Nakata, N
Endoh, M
Singh, RP
Kasama, T
Saito, H
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 88 (03): : 226 - 231
[9] Amazonian Purine Nucleoside Phosphorylase Deficient Patient - First Brazilian Case Report
Ribeiro, Suelen
Silva, Maielly
Feliciano, Poliana
Valente, Claudia
Carvalho, Beatriz
Neto, Antonio
Kanegae, Marilia
Hershfield, Michael
Albuquerque, Luciana
Macedo, Antonio
Scancetti, Fabiola
JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 : S46 - S47
[10] Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis
Yamano, T
Higashi, T
Nouso, K
Nakatsukasa, H
Kariyama, K
Yumoto, E
Kobayashi, Y
Yamamoto, K
Iwagaki, H
Yagi, T
Tanimoto, T
Kurimoto, M
Tanaka, N
Tsuji, T
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (02): : 227 - 231

← 1 2 3 4 5 →